ATE511858T1 - 2,4,6-triamino-1,3,5-triazin-derivat - Google Patents
2,4,6-triamino-1,3,5-triazin-derivatInfo
- Publication number
- ATE511858T1 ATE511858T1 AT03737464T AT03737464T ATE511858T1 AT E511858 T1 ATE511858 T1 AT E511858T1 AT 03737464 T AT03737464 T AT 03737464T AT 03737464 T AT03737464 T AT 03737464T AT E511858 T1 ATE511858 T1 AT E511858T1
- Authority
- AT
- Austria
- Prior art keywords
- bec
- potassium channel
- triamino
- action
- channel inhibitor
- Prior art date
Links
- 150000007974 melamines Chemical class 0.000 title 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 5
- 108020001213 potassium channel Proteins 0.000 abstract 5
- 229940125400 channel inhibitor Drugs 0.000 abstract 3
- 208000020358 Learning disease Diseases 0.000 abstract 2
- 201000003723 learning disability Diseases 0.000 abstract 2
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940125682 antidementia agent Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002028844 | 2002-02-05 | ||
| PCT/JP2003/001065 WO2003066099A1 (en) | 2002-02-05 | 2003-02-03 | 2,4,6-triamino-1,3,5-triazine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511858T1 true ATE511858T1 (de) | 2011-06-15 |
Family
ID=27677870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03737464T ATE511858T1 (de) | 2002-02-05 | 2003-02-03 | 2,4,6-triamino-1,3,5-triazin-derivat |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7375222B2 (de) |
| EP (1) | EP1479397B1 (de) |
| JP (1) | JP4325402B2 (de) |
| KR (2) | KR100875362B1 (de) |
| CN (3) | CN1939307A (de) |
| AT (1) | ATE511858T1 (de) |
| AU (1) | AU2003244463A1 (de) |
| CA (1) | CA2475432C (de) |
| ES (1) | ES2364645T3 (de) |
| MX (1) | MXPA04007590A (de) |
| PT (1) | PT1479397E (de) |
| WO (1) | WO2003066099A1 (de) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO5380035A1 (es) * | 2001-03-23 | 2004-03-31 | Aventis Pharma Sa | Derivados quimicos y su aplicacion como agente antitelomerasa |
| US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| ATE511858T1 (de) * | 2002-02-05 | 2011-06-15 | Astellas Pharma Inc | 2,4,6-triamino-1,3,5-triazin-derivat |
| CL2004000303A1 (es) * | 2003-02-20 | 2005-04-08 | Tibotec Pharm Ltd | Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih. |
| WO2005003103A2 (en) * | 2003-06-30 | 2005-01-13 | Astrazeneca Ab | 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases |
| CN1629157A (zh) * | 2003-12-19 | 2005-06-22 | 中国科学院上海药物研究所 | 哌嗪三嗪类化合物、其制备方法及药物组合物 |
| ITMI20050222A1 (it) * | 2005-02-15 | 2006-08-16 | Milano Politecnico | Lipidi cationici per la trasfezione di acidi nucleici |
| US7345178B2 (en) * | 2005-08-04 | 2008-03-18 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| JP5268652B2 (ja) * | 2006-02-01 | 2013-08-21 | メルク・シャープ・アンド・ドーム・コーポレーション | カリウムチャンネルインヒビター |
| WO2007095812A1 (en) * | 2006-02-27 | 2007-08-30 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof |
| JP2009545592A (ja) * | 2006-07-31 | 2009-12-24 | プリーシス・ファーマシューティカルズ・インコーポレイテッド | コード化小分子ライブラリーからのオーロラキナーゼ阻害剤 |
| JP5622393B2 (ja) | 2006-12-15 | 2014-11-12 | アブラクシスバイオサイエンス リミテッド ライアビリティー カンパニー | トリアジン誘導体類及びそれらの治療応用 |
| US8252803B2 (en) * | 2007-02-12 | 2012-08-28 | Merck Sharp & Dohme Corp. | Piperidine derivatives |
| WO2008131547A1 (en) * | 2007-04-30 | 2008-11-06 | Prometic Biosciences Inc. | 'triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives' |
| US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
| TW200916472A (en) | 2007-06-20 | 2009-04-16 | Sirtris Pharmaceuticals Inc | Sirtuin modulating compounds |
| TWI389893B (zh) | 2007-07-06 | 2013-03-21 | Astellas Pharma Inc | 二（芳胺基）芳基化合物 |
| US8415340B2 (en) | 2007-07-25 | 2013-04-09 | Bristol-Myers Squibb Company | Triazine kinase inhibitors |
| EA019104B1 (ru) | 2007-09-21 | 2014-01-30 | Эррей Биофарма Инк. | Активаторы глюкокиназы |
| EP2217068A4 (de) * | 2007-10-11 | 2011-09-14 | Glaxosmithkline Llc | Neue seh-hemmer und ihre verwendung |
| JP5411867B2 (ja) * | 2007-10-11 | 2014-02-12 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規ｓＥＨ阻害剤およびそれらの使用 |
| MY157116A (en) * | 2007-10-11 | 2016-05-13 | Glaxosmithkline Llc | Novel seh inhibitors and their use |
| US7868001B2 (en) * | 2007-11-02 | 2011-01-11 | Hutchison Medipharma Enterprises Limited | Cytokine inhibitors |
| KR101247840B1 (ko) | 2008-02-22 | 2013-03-26 | 에프. 호프만-라 로슈 아게 | 아밀로이드 베타 조절제 |
| JP5502089B2 (ja) * | 2008-10-09 | 2014-05-28 | エフ．ホフマン−ラ ロシュ アーゲー | アミロイドβのモジュレーター |
| CN102209537A (zh) | 2008-11-10 | 2011-10-05 | 弗·哈夫曼-拉罗切有限公司 | 杂环γ分泌酶调节剂 |
| CA2660954A1 (en) * | 2009-03-31 | 2010-09-30 | Astellas Pharma Inc. | Novel salt of 1,3,5-triazine-2,4,6-triamine derivative |
| CA2660962A1 (en) | 2009-03-31 | 2010-09-30 | Astellas Pharma Inc. | Novel pharmaceutical composition for treatment of schizophrenia |
| US8399663B2 (en) * | 2009-04-03 | 2013-03-19 | Astellas Pharma Inc. | Salt of 1,3,5-triazine-2,4,6-triamine derivative |
| US20100256152A1 (en) * | 2009-04-03 | 2010-10-07 | Astellas Pharma Inc. | Novel pharmaceutical composition for treatment of schizophrenia |
| CA2762528A1 (en) * | 2009-05-29 | 2010-12-02 | Astellas Pharma Inc. | Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder |
| CA2765030C (en) * | 2009-06-09 | 2015-10-27 | California Capital Equity, Llc | Triazine derivatives and their therapeutical applications |
| WO2011037610A1 (en) * | 2009-09-23 | 2011-03-31 | Albert Einstein College Of Medicine Of Yeshiva University | Prostaglandin transporter inhibitors and uses thereof |
| EP2332926A1 (de) | 2009-11-23 | 2011-06-15 | Borealis Agrolinz Melamine GmbH | Auf Melamin basierende Mannich-Verbindungen und Herstellungsverfahren dafür |
| US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
| CN102070619B (zh) * | 2010-11-29 | 2013-06-05 | 河北大学 | 一种三嗪衍生物及制备方法和其在植物抗菌剂中的应用 |
| JP2012153674A (ja) * | 2011-01-28 | 2012-08-16 | Astellas Pharma Inc | ジ（アリールアミノ）アリール化合物の製造方法及びその合成中間体 |
| KR101472083B1 (ko) * | 2012-10-22 | 2014-12-16 | 광주과학기술원 | ＥＮＯｂｌｏｃｋ을 유효성분으로 포함하는 암 예방 또는 치료용 약제학적 조성물 |
| EP2774922A1 (de) * | 2013-03-04 | 2014-09-10 | Borealis Agrolinz Melamine GmbH | Verfahren zum Erhalten einer funktionalisierten Triazinverbindung und die mit dem Verfahren erhaltene Triazinverbindung |
| US9914709B2 (en) * | 2013-06-21 | 2018-03-13 | Yale University | Compositions and methods of treating HIV-1 infections using same |
| UA116571C2 (uk) | 2013-07-16 | 2018-04-10 | Басф Се | Гербіцидні азини |
| EP3122736A1 (de) * | 2014-03-28 | 2017-02-01 | Basf Se | Diaminotriazinderivate als herbizide |
| US10941122B2 (en) | 2014-04-11 | 2021-03-09 | Basf Se | Diaminotriazine derivatives as herbicides |
| CR20160545A (es) | 2014-04-23 | 2017-03-31 | Basf Se | Compuestos de diaminotriazina como herbicidas |
| EP3134391A1 (de) * | 2014-04-23 | 2017-03-01 | Basf Se | Diaminotriazinverbindungen und deren verwendung als herbizide |
| WO2016059647A2 (en) * | 2014-10-13 | 2016-04-21 | SHRI CHHATRAPTI SHIVAJI COLLEGE Maharashtra, India) | Triaminotriazine picolinonitrile derivatives as potent reverse transcriptase inhibitor of hiv-1 |
| CN105294588A (zh) * | 2015-11-25 | 2016-02-03 | 武汉工程大学 | 含氟三嗪衍生物及其制备方法和用途 |
| WO2018230595A1 (ja) * | 2017-06-14 | 2018-12-20 | 富士フイルム株式会社 | 組成物、膜、レンズ、固体撮像素子、化合物 |
| CN108276351A (zh) * | 2018-02-11 | 2018-07-13 | 天津大学 | 具有潜在抗癌效果化合物及其测定方法 |
| KR102022323B1 (ko) * | 2018-03-30 | 2019-09-18 | 정하윤 | 트리아진 화합물 및 이의 용도 |
| CN111662242B (zh) * | 2019-03-08 | 2023-10-24 | 中国药科大学 | 杂环类idh突变体抑制剂、其制备方法及用途 |
| CN112759557B (zh) * | 2019-11-04 | 2023-12-29 | 圣奥化学科技有限公司 | 具有抗老化和耐变色功效的化合物及其制备方法 |
| KR20230040022A (ko) * | 2021-09-15 | 2023-03-22 | 주식회사 펩토이드 | 다제 내성균 항균 조성물 및 그의 제조방법 |
| WO2024128802A1 (ko) * | 2022-12-15 | 2024-06-20 | 부산대학교 산학협력단 | 간과 신장의 염증 및 섬유화 치료 효과가 있는 신규 트리아진 유도체 및 이의 제조방법 |
| WO2025116280A1 (ko) * | 2023-11-29 | 2025-06-05 | 주식회사 펩토이드 | 새로운 대칭형 플루오로트리아진 화합물 및 이들의 의학적 또는 생물학적 용도 |
| CN117624137A (zh) * | 2023-12-04 | 2024-03-01 | 中国药科大学 | 三嗪骨架小分子肝素逆转剂及其制备方法与用途 |
| CN119859160A (zh) * | 2024-12-20 | 2025-04-22 | 中国科学院长春应用化学研究所 | 一种功能性己内酰胺、本征型阻燃尼龙材料及其制备方法和应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB951667A (en) | 1961-04-25 | 1964-03-11 | Ici Ltd | New water soluble azo dyestuffs containing quaternary ammonium groups |
| JPS5111861Y2 (de) | 1971-06-11 | 1976-03-31 | ||
| DE3440777C2 (de) | 1983-11-14 | 1998-09-03 | Clariant Finance Bvi Ltd | Neue sulfonsäuregruppenhaltige, basische Azoverbindungen, deren Herstellung und Verwendung als Farbstoffe |
| JPS61246261A (ja) | 1985-04-25 | 1986-11-01 | Toyo Ink Mfg Co Ltd | 顔料分散剤 |
| IL87542A (en) * | 1987-08-28 | 1993-01-31 | Uniroyal Chem Co Inc | Arylenediamino substituted triazine derivatives, processes for the preparation thereof and compositions containing the same |
| US4794135A (en) * | 1987-08-28 | 1988-12-27 | Uniroyal Chemical Company, Inc. | Arylenediamine substituted triazines |
| CH684948A5 (de) | 1992-05-13 | 1995-02-15 | Sandoz Ag | Basische sulfogruppenhaltige Disazoverbindungen. |
| DE4430094A1 (de) * | 1994-08-25 | 1996-02-29 | Bayer Ag | Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel |
| US6117996A (en) | 1995-09-20 | 2000-09-12 | Novo Nordisk A/S | Triazine based ligands and use thereof |
| WO1997042267A1 (en) * | 1996-05-03 | 1997-11-13 | Alliedsignal Inc. | Novel nylon compositions |
| ES2188883T3 (es) * | 1996-07-08 | 2003-07-01 | Ciba Sc Holding Ag | Derivados de triazina como filtro uv en productos antisolares. |
| JP3967783B2 (ja) | 1996-07-31 | 2007-08-29 | 富士フイルム株式会社 | 顔料分散組成物及びそれを用いた着色感光性組成物 |
| IT1284525B1 (it) | 1996-09-13 | 1998-05-21 | 3V Sigma Spa | Derivati di benzossazolo loro uso come stabilizzanti contro le radiazioni uv |
| WO1999001442A1 (en) * | 1997-07-02 | 1999-01-14 | Zeneca Limited | Triazine derivatives and their use as antibacterial agents |
| JPH1143448A (ja) | 1997-07-09 | 1999-02-16 | Nippon Soda Co Ltd | フェノール系分子化合物を使用する反応方法 |
| DE19735800A1 (de) * | 1997-08-18 | 1999-02-25 | Boehringer Ingelheim Pharma | Triazine mit adenosinantagonistischer Wirkung |
| JPH11158073A (ja) | 1997-09-26 | 1999-06-15 | Takeda Chem Ind Ltd | アデノシンａ３拮抗剤 |
| US6123763A (en) | 1997-12-22 | 2000-09-26 | Toyo Ink Mfg. Co., Ltd. | Pigment dispersing agent and pigment composition containing the same |
| JP3518300B2 (ja) | 1997-11-17 | 2004-04-12 | 東洋インキ製造株式会社 | 顔料分散剤、及びそれを含有する顔料組成物 |
| US6335339B1 (en) | 1998-01-13 | 2002-01-01 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| JP2002509140A (ja) | 1998-01-13 | 2002-03-26 | アナディーズ・ファーマスーティカルズ，インコーポレイテッド | トリアジン抗ウイルス化合物 |
| AU1982799A (en) | 1998-01-23 | 1999-08-09 | Yamanouchi Pharmaceutical Co., Ltd. | Novel potassium channel protein |
| EP0945447A1 (de) * | 1998-03-27 | 1999-09-29 | Janssen Pharmaceutica N.V. | Trisubstituierte 1,3,5-Triazinderivate zur Behandlung von HIV Infektionen |
| DE69924493T2 (de) * | 1998-07-02 | 2005-09-15 | Neurosearch A/S | Kaliumkanal-blockierende mittel |
| US20020099197A1 (en) * | 1998-07-21 | 2002-07-25 | Rory A.J. Curtis | Novel potassium channel molecules and uses therefor |
| WO2000069823A1 (en) | 1999-05-12 | 2000-11-23 | Neurosearch A/S | Ion channel modulating agents |
| US6262053B1 (en) * | 1999-06-23 | 2001-07-17 | Parker Hughes Institute | Melamine derivatives as potent anti-cancer agents |
| ATE250610T1 (de) | 1999-06-29 | 2003-10-15 | Neurosearch As | Kaliumkanal-blockierende mittel |
| TR200200763T2 (tr) | 1999-09-24 | 2003-09-22 | Janssen Pharmaceutica N.V. | Antiviral bileşimler |
| WO2001066743A2 (en) | 2000-03-03 | 2001-09-13 | Millennium Pharmaceuticals, Inc. | A potassium channel molecule and uses therefor |
| US6630469B2 (en) * | 2000-05-09 | 2003-10-07 | Bristol-Myers Squibb Company | 5-HT7 receptor antagonists |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| CA2465978C (en) | 2001-09-14 | 2015-04-07 | Soon Hyung Woo | Inhibitors of histone deacetylase |
| PL369600A1 (en) | 2001-09-21 | 2005-05-02 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| CA2465337A1 (en) * | 2001-11-14 | 2003-05-22 | Yamanouchi Pharmaceutical Co., Ltd. | Transgenic animal |
| ATE511858T1 (de) * | 2002-02-05 | 2011-06-15 | Astellas Pharma Inc | 2,4,6-triamino-1,3,5-triazin-derivat |
-
2003
- 2003-02-03 AT AT03737464T patent/ATE511858T1/de active
- 2003-02-03 JP JP2003565522A patent/JP4325402B2/ja not_active Expired - Fee Related
- 2003-02-03 AU AU2003244463A patent/AU2003244463A1/en not_active Abandoned
- 2003-02-03 CA CA2475432A patent/CA2475432C/en not_active Expired - Fee Related
- 2003-02-03 CN CNA2006100958976A patent/CN1939307A/zh active Pending
- 2003-02-03 ES ES03737464T patent/ES2364645T3/es not_active Expired - Lifetime
- 2003-02-03 CN CN201110039025.9A patent/CN102151273B/zh not_active Expired - Fee Related
- 2003-02-03 US US10/503,494 patent/US7375222B2/en not_active Expired - Fee Related
- 2003-02-03 PT PT03737464T patent/PT1479397E/pt unknown
- 2003-02-03 WO PCT/JP2003/001065 patent/WO2003066099A1/ja not_active Ceased
- 2003-02-03 MX MXPA04007590A patent/MXPA04007590A/es active IP Right Grant
- 2003-02-03 EP EP03737464A patent/EP1479397B1/de not_active Expired - Lifetime
- 2003-02-03 CN CNA038031310A patent/CN1625410A/zh active Pending
- 2003-02-03 KR KR1020067005956A patent/KR100875362B1/ko not_active Expired - Fee Related
- 2003-02-03 KR KR1020047012037A patent/KR100581309B1/ko not_active Expired - Fee Related
-
2008
- 2008-02-06 US US12/027,246 patent/US20080227785A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2475432C (en) | 2011-04-05 |
| US20060194803A1 (en) | 2006-08-31 |
| MXPA04007590A (es) | 2004-12-06 |
| US7375222B2 (en) | 2008-05-20 |
| CN102151273B (zh) | 2015-11-25 |
| CA2475432A1 (en) | 2003-08-14 |
| PT1479397E (pt) | 2011-09-01 |
| EP1479397A4 (de) | 2009-01-07 |
| KR20040081485A (ko) | 2004-09-21 |
| AU2003244463A1 (en) | 2003-09-02 |
| KR100581309B1 (ko) | 2006-05-22 |
| KR20060030922A (ko) | 2006-04-11 |
| KR100875362B1 (ko) | 2008-12-22 |
| JP4325402B2 (ja) | 2009-09-02 |
| CN1939307A (zh) | 2007-04-04 |
| WO2003066099A1 (en) | 2003-08-14 |
| EP1479397B1 (de) | 2011-06-08 |
| CN1625410A (zh) | 2005-06-08 |
| JPWO2003066099A1 (ja) | 2005-05-26 |
| US20080227785A1 (en) | 2008-09-18 |
| CN102151273A (zh) | 2011-08-17 |
| ES2364645T3 (es) | 2011-09-08 |
| EP1479397A1 (de) | 2004-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1479397E (pt) | Derivados de 2,4,6-triamino-1,3,5-triazina | |
| DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
| GT200300040A (es) | Composicion de ziprasidona y controles sinteticos | |
| MXPA04002167A (es) | Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
| DE60142921D1 (de) | Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren | |
| BRPI0412763A (pt) | formas anidras, hidratadas ou solvatadas de um composto, forma cristalina, composição farmacêutica, e, método para o tratamento ou a profilaxia de distúrbios | |
| CR7332A (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
| ATE481093T1 (de) | Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit | |
| DK1723144T3 (da) | Yderligere heteropolycykliske forbindelser og anvendelse deraf som metabotropiske glutamareceptor-antagonister | |
| CY1111246T1 (el) | Προληψη και θεραπεια επαγομενης απο φλεγμονη και/ή ανοσοδιαμεσολαβουμενης οστικης απωλειας | |
| DK1404324T3 (da) | Prolægemidler af GABA analoger, sammensætninger og anvendelser deraf | |
| MXPA05009535A (es) | Compuestos de acido n - alquil - hidroxamico - isoindolilo y sus usos farmaceuticos. | |
| EP1477482A4 (de) | Neues phenylalaninderivat | |
| NO20070529L (no) | Kinazolindionderivater som parp-inhibitorer | |
| NO20044442L (no) | Fosfatprodroger av fluoroksindoler | |
| CY1110343T1 (el) | 2-(πυριδιν-2-υλο)-πυριμιδινες και η χρησιμοποιηση του για την καταπολεμηση επιζημιων μυκητων | |
| HN2003000063A (es) | Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades. | |
| DK1855677T3 (da) | 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
| MY143677A (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
| ATE466007T1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
| PT1042954E (pt) | Composicoes e metodos herbicidas sinergicos compreendendo compostos de dinitroanilina e imidazolinona | |
| DE60108209D1 (de) | Fungizide Phenylimidate-Derivate | |
| MXPA03011790A (es) | Agente para la procteccion de neuronas de la retina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1479397 Country of ref document: EP |